ArticleCardiovascular diabetology2026
Association of cumulative cholesterol-HDL-glucose index with blood pressure changes and risk of new-onset hypertension in middle-aged and older adults: a cohort study.
Article in Cardiovascular diabetology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Baseline versus cumulative cholesterol, high-density lipoprotein, and glucose index and stroke risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: evidence from the CHARLS study.Cardiovascular diabetology. Endocrinology reports · 2026Article
- Association of baseline and cumulative CHG index with risk of new-onset sarcopenia in middle-aged and older adults.The journal of nutrition, health & aging · 2026Article
- Predictive value of cholesterol, high-density lipoprotein, and glucose index-obesity-derived index for stroke: a cohort study.Lipids in health and disease · 2026Article
- Predictive value of the combined cholesterol, high-density lipoprotein, glucose and frailty indices for cardiometabolic multimorbidity incidence: evidence from a national prospective cohort study.Cardiovascular diabetology · 2026Article
- Comparative evaluation of nine insulin resistance indices for 10-year coronary artery disease risk prediction in non-diabetic adults.Scientific reports · 2026Article
- The combined impact of social isolation and unhealthy risk score on mortality risk: a study from two prospective cohorts.BMC public health · 2026Article
- Associations between cholesterol, high-density lipoprotein, and glucose index and hyperuricemia in patients with diabetes.BMC endocrine disorders · 2026Article
- Cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose index (CTI) versus the cholesterol, high-density lipoprotein, and glucose index (CHG) for incident hypertension prediction: a national cohort study.Cardiovascular diabetology · 2026Article
- Associations of cumulative exposure and dynamic trajectories of cholesterol-HDL-glucose (CHG) index with cardiovascular disease in middle-aged and older Chinese adults: a longitudinal analysis.Cardiovascular diabetology · 2026Article
- Cumulative exposure and patterns of the cholesterol-HDL-C-glucose index and risk of new-onset cardiometabolic multimorbidity: 9-year longitudinal evidence from CHARLS.Frontiers in nutrition · 2026Article
- Joint assessment of white blood cell-to-HDL cholesterol ratio and waist-to-height-hemoglobin A1c for cardiometabolic multimorbidity risk: a prospective cohort study and cross-sectional study.Frontiers in nutrition · 2026Article
- Exploratory mediation analysis of body roundness index in the nonlinear association between CHG index and metabolic dysfunction-associated steatotic liver disease among non-diabetic adults.Frontiers in nutrition · 2026Article
- Cholesterol, high-density lipoprotein, and glucose index as a cardiometabolic marker associated with heart rate variability and 1-year cardiovascular rehospitalization in chronic coronary syndromes with comorbid anxiety: a retrospective cohort study.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundHypertension is a major risk factor for cardiovascular diseases and represents a primary global public health concern. A newer index, the Cholesterol, High-Density Lipoprotein, and Glucose (CHG) index, has been proposed as a novel indicator for diagnosing type 2 diabetes and has recently been demonstrated to predict cardiovascular diseases (CVD). However, the associations of elevated CHG index and its cumulative measures with blood pressure changes and the new-onset hypertension risk in middle-aged and older adults remain unclear.
methodsParticipants from the China Health and Retirement Longitudinal Study (CHARLS) were recruited as the longitudinal cohort for this study, with 2011 as the baseline year and follow-up in 2015. K-means clustering analysis was employed to categorize participants into two groups based on cumulative CHG over the 4-year period. Multivariable logistic regression was used to examine the associations between CHG and cumulative CHG indicators across different groups and the incidence of hypertension, while multivariable linear regression models were applied to assess the relationship between cumulative CHG indicators in different groups and changes in blood pressure. Restricted cubic spline (RCS) regression models were utilized to investigate potential nonlinear associations between cumulative CHG and hypertension events. Receiver operating characteristic (ROC) curves were employed to quantify the predictive performance of CHG and cumulative CHG for incident hypertension.
resultsIn our study, K-means clustering analysis was employed to categorize participants into two groups based on changes in cumulative CHG. Compared with the first group, where cumulative CHG remained consistently low and stable, the second group exhibited higher baseline mean blood pressure. Furthermore, during the follow-up period, the second group demonstrated significantly greater increases in blood pressure and elevated risk of incident hypertension, with β coefficients of 3.89 (95% CI: 2.23–5.55) for systolic blood pressure and 0.93 (95% CI: 0.35–1.50) for diastolic blood pressure, as well as an odds ratio (OR) of 1.61 (95% CI: 1.26–2.07) for incident hypertension. Similar findings were observed when participants were stratified by cumulative CHG quartiles: compared with the Q1 group, the Q4 group showed higher systolic blood pressure by 4.83 mmHg (95% CI: 2.58–7.08), higher diastolic blood pressure by 1.52 mmHg (95% CI: 0.12–2.93), and a 1.72-fold increased risk of incident hypertension events (95% CI: 1.21–2.43). Unrestricted cubic spline plots revealed a linear association between cumulative CHG and the aforementioned outcomes. ROC curves indicated that the predictive performance of cumulative CHG for incident hypertension was comparable to that of cumulative AIP. Subgroup analyses demonstrated interactions between the cumulative CHG index and CVD or CKD, warranting particular attention to patients with CVD or CKD.
conclusionsOur findings indicate that an elevated cumulative CHG index serves as an independent risk factor for incident hypertension in middle-aged and elderly populations. Although CHG levels exhibited a population-wide decline during the follow-up period, baseline levels were more effective in identifying individuals at long-term high risk. This underscores the importance of initiating early, sustained, and intensified comprehensive risk management in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.